{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:40:38Z","timestamp":1792197638144,"version":"4.4.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10787-026-02385-1","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:47:17Z","timestamp":1788533237000},"page":"6347-6362","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular target for neuroinflammation and pain management: transient receptor potential vanilloid 1"],"prefix":"10.1007","volume":"34","author":[{"given":"Zunera","family":"Chauhdary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Saad","family":"Masood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Irfan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Shafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duryab","family":"Rafique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeesha","family":"Arif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Akmal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"2385_CR1","doi-asserted-by":"crossref","unstructured":"Abdalla, S., Harb, A., Almasri, I. & Bustanji, Y. 2022. The interaction of TRPV1 and lipids: Insights into lipid metabolism. Front Physiol 13.","DOI":"10.3389\/fphys.2022.1066023"},{"key":"2385_CR2","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/med.21427","volume":"37","author":"M Aghazadeh Tabrizi","year":"2017","unstructured":"Aghazadeh Tabrizi M, Baraldi PG, Baraldi S, Gessi S, Merighi S, Borea PA (2017) Medicinal chemistry, pharmacology, and clinical implications of TRPV1 receptor antagonists. Med Res Rev 37:936\u2013983","journal-title":"Med Res Rev"},{"key":"2385_CR3","volume":"16","author":"ACM Andrade","year":"2025","unstructured":"Andrade ACM, Molina Esquivel N, Goldschmied Rossel F, Benso B (2025) TRPV1-target drugs for the treatment of orofacial pain. Front Pharmacol 16:1568109","journal-title":"Front Pharmacol"},{"key":"2385_CR4","first-page":"339","volume":"12","author":"C Andrei","year":"2023","unstructured":"Andrei C, Zanfirescu A, Ni\u021bulescu GM, Olaru OT, Negre\u0219 S (2023) Natural active ingredients and TRPV1 modulation: focus on key chemical moieties involved in ligand\u2013target interaction. Plants (Basel) 12:339","journal-title":"Plants (Basel)"},{"key":"2385_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/toxins17020064","author":"F Beignon","year":"2025","unstructured":"Beignon F, Notais M, Diochot S, Baron A, Fajloun Z, Tricoire-Leignel H, Lenaers G, Mattei C (2025) Neurotoxins acting on TRPV1\u2014building a molecular template for the study of pain and thermal dysfunctions. Toxins (Basel). https:\/\/doi.org\/10.3390\/toxins17020064","journal-title":"Toxins (Basel)"},{"key":"2385_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21103421","author":"M Ben\u00edtez-Angeles","year":"2020","unstructured":"Ben\u00edtez-Angeles M, Morales-L\u00e1zaro S, Ju\u00e1rez-Gonz\u00e1lez E, Rosenbaum T (2020) TRPV1: structure, endogenous agonists, and mechanisms. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21103421","journal-title":"Int J Mol Sci"},{"key":"2385_CR7","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2023.106771","volume":"169","author":"N Birkic","year":"2023","unstructured":"Birkic N, Visentin D, Svedru\u017ei\u0107 \u017d, Reynolds CA (2023) Binding interactions of fatty acyl lipid mediators within the vanilloid pocket of TRPV1: a molecular dynamics study. Prostaglandins Other Lipid Mediat 169:106771","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"2385_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21030821","author":"V Cernit","year":"2020","unstructured":"Cernit V, S\u00e9n\u00e9cal J, Othman R, Couture R (2020) Reciprocal regulatory interaction between TRPV1 and kinin B1 receptor in a rat neuropathic pain model. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21030821","journal-title":"Int J Mol Sci"},{"key":"2385_CR9","doi-asserted-by":"crossref","DOI":"10.3390\/ph17060756","volume":"17","author":"LA Chahl","year":"2024","unstructured":"Chahl LA (2024) TRPV1 channels in the central nervous system as drug targets. Pharmaceuticals (Basel) 17:756","journal-title":"Pharmaceuticals (Basel)"},{"key":"2385_CR10","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jointm.2024.01.008","volume":"4","author":"J Chen","year":"2024","unstructured":"Chen J, Sun W, Zhu Y, Zhao F, Deng S, Tian M, Wang Y, Gong Y (2024) TRPV1: the key bridge in neuroimmune interactions. J Intensive Med 4:442\u2013452","journal-title":"J Intensive Med"},{"key":"2385_CR11","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107837","volume":"218","author":"H Chen","year":"2025","unstructured":"Chen H, Xu N, Kam H, Zhao C, Chen Q, Fan G, Siu SWI, Wong CTT, Qiu J-W, Cheung AK-K (2025b) A TRPV1 agonist from the transcriptome profiling of Dipsastraea rotumana inhibits neuroinflammation in vivo through the NF-\u03baB and MAPK pathways. Pharmacol Res 218:107837","journal-title":"Pharmacol Res"},{"key":"2385_CR12","doi-asserted-by":"crossref","unstructured":"Chen, F., Hao, K., Shu, C., Xiong, Y., Xu, R., Huang, H., Peng, B., Liu, Z., Reynolds, G., Wang, G. & Wang, H. 2025a. TRPV1 suppresses microglial inflammatory activation to ameliorate schizophrenia-associated behaviors in maternal separation rats. Schizophr Bull 52.","DOI":"10.1093\/schbul\/sbaf153"},{"key":"2385_CR13","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29194729","volume":"29","author":"SR Chinreddy","year":"2024","unstructured":"Chinreddy SR, Mashozhera NT, Rashrash B, Flores-Iga G, Nimmakayala P, Hankins GR, Harris RT, Reddy UK (2024) Unraveling TRPV1\u2019s role in cancer: expression, modulation, and therapeutic opportunities with capsaicin. Molecules 29:4729","journal-title":"Molecules"},{"key":"2385_CR14","first-page":"5954890","volume":"2016","author":"S-I Choi","year":"2016","unstructured":"Choi S-I, Lim JY, Yoo S, Kim H, Hwang SW (2016) Emerging role of spinal cord TRPV1 in pain exacerbation. Neural Plast 2016:5954890","journal-title":"Neural Plast"},{"key":"2385_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119553","author":"Y-Y Chu","year":"2023","unstructured":"Chu Y-Y, Zhang H, Yang M-Q, Yu R-L (2023a) Molecular dynamic simulations reveal the activation mechanisms of oxidation-induced TRPV1. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24119553","journal-title":"Int J Mol Sci"},{"key":"2385_CR16","volume":"24","author":"Y Chu","year":"2023","unstructured":"Chu Y, Zhang H, Yang M, Yu R (2023b) Molecular dynamic simulations reveal the activation mechanisms of oxidation-induced TRPV1. Int J Mol Sci 24:9553","journal-title":"Int J Mol Sci"},{"key":"2385_CR17","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/j.1476-5381.2010.00862.x","volume":"160","author":"M Connor","year":"2010","unstructured":"Connor M, Vaughan CW, Vandenberg RJ (2010) N-Acyl amino acids and N-acyl neurotransmitter conjugates: neuromodulators and probes for new drug targets. Br J Pharmacol 160:1857\u20131871","journal-title":"Br J Pharmacol"},{"key":"2385_CR18","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12974-016-0738-9","volume":"13","author":"F Corrigan","year":"2016","unstructured":"Corrigan F, Mander KA, Leonard AV, Vink R (2016) Neurogenic inflammation after traumatic brain injury and its potentiation of classical inflammation. J Neuroinflammation 13:264","journal-title":"J Neuroinflammation"},{"key":"2385_CR19","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1111\/bph.16173","volume":"180","author":"J Daniluk","year":"2023","unstructured":"Daniluk J, Voets T (2023) PH-dependent modulation of TRPV1 by modality-selective antagonists. Br J Pharmacol 180:2750\u20132761","journal-title":"Br J Pharmacol"},{"key":"2385_CR20","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70444","volume":"170","author":"M De Las Casas","year":"2026","unstructured":"De Las Casas M, Hern\u00e1ndez\u2010Ortego P, Torres\u2010Montero R, De La Pe\u00f1a E, Gomis A, Viana F, Fern\u00e1ndez\u2010Trillo J (2026) Validation of TRPA1 and TRPV1 antibodies for expression detection in mammalian cells and tissues. J Neurochem 170:e70444","journal-title":"J Neurochem"},{"key":"2385_CR21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/13543776.2025.2467698","volume":"35","author":"I Devesa","year":"2025","unstructured":"Devesa I, Fern\u00e1ndez-Ballester G, Fernandez-Carvajal A, Ferrer-Montiel A (2025) A review of the patent literature surrounding TRPV1 modulators. Expert Opin Ther Pat 35:477\u2013491","journal-title":"Expert Opin Ther Pat"},{"key":"2385_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21010342","author":"M Dux","year":"2020","unstructured":"Dux M, Rosta J, Messlinger K (2020) TRP channels in the focus of trigeminal nociceptor sensitization contributing to primary headaches. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21010342","journal-title":"Int J Mol Sci"},{"key":"2385_CR23","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3390\/biom13060983","volume":"13","author":"N Erin","year":"2023","unstructured":"Erin N, Szallasi A (2023) Carcinogenesis and metastasis: focus on TRPV1-positive neurons and immune cells. Biomolecules 13:983","journal-title":"Biomolecules"},{"key":"2385_CR24","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Carvajal, A., Fern\u00e1ndez-Ballester, G. & Ferrer-Montiel, A. 2022. TRPV1 in chronic pruritus and pain: Soft modulation as a therapeutic strategy. Frontiers in Molecular Neuroscience, 15.","DOI":"10.3389\/fnmol.2022.930964"},{"key":"2385_CR25","volume":"17","author":"N Gao","year":"2024","unstructured":"Gao N, Li M, Wang W, Liu Z, Guo Y (2024b) The dual role of TRPV1 in peripheral neuropathic pain: pain switches caused by its sensitization or desensitization. Front Mol Neurosci 17:1400118","journal-title":"Front Mol Neurosci"},{"key":"2385_CR26","doi-asserted-by":"crossref","unstructured":"Gao, N., Li, M., Wang, W., Liu, Z. & Guo, Y. 2024a. The dual role of TRPV1 in peripheral neuropathic pain: pain switches caused by its sensitization or desensitization. Frontiers in Molecular Neuroscience, 17.","DOI":"10.3389\/fnmol.2024.1400118"},{"key":"2385_CR27","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2023.1138577","volume":"15","author":"J Goenaga","year":"2023","unstructured":"Goenaga J, Araque A, Kofuji P, Herrera Moro Chao D (2023) Calcium signaling in astrocytes and gliotransmitter release. Front Synaptic Neurosci 15:1138577","journal-title":"Front Synaptic Neurosci"},{"key":"2385_CR28","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s13238-017-0395-5","volume":"8","author":"O Gouin","year":"2017","unstructured":"Gouin O, L\u2019Herondelle K, Lebonvallet N, Le Gall-Ianotto C, Sakka M, Buh\u00e9 V, Pl\u00e9e-Gautier E, Carr\u00e9 J-L, Lefeuvre L, Misery L (2017) TRPV1 and TRPA1 in cutaneous neurogenic and chronic inflammation: pro-inflammatory response induced by their activation and their sensitization. Protein Cell 8:644\u2013661","journal-title":"Protein Cell"},{"key":"2385_CR29","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1097\/j.pain.0000000000001346","volume":"159","author":"Y Gu","year":"2018","unstructured":"Gu Y, Li G, Huang L (2018) Inflammation induces Epac-protein kinase C alpha and epsilon signaling in TRPV1-mediated hyperalgesia. Pain 159:2383","journal-title":"Pain"},{"key":"2385_CR30","doi-asserted-by":"crossref","unstructured":"He, S., Zambelli, V., Sinharoy, P., Brabenec, L., Bian, Y., Rwere, F., Hell, R. C., Neto, B. S., Hung, B., Yu, X., Zhao, M., Luo, Z., Wu, C., Xu, L., Svensson, K., Mcallister, S., Stary, C., Wagner, N.-M., Zhang, Y. & Gross, E. 2022. A human TRPV1 genetic variant within the channel gating domain regulates pain sensitivity in rodents. J Clinic Invest, 133.","DOI":"10.1172\/JCI163735"},{"key":"2385_CR31","doi-asserted-by":"crossref","unstructured":"He, S., Zambelli, V. O., Sinharoy, P., Brabenec, L., Bian, Y., Rwere, F., Hell, R. C., Neto, B. S., Hung, B. & Yu, X. 2023. A human TRPV1 genetic variant within the channel gating domain regulates pain sensitivity in rodents. J Clinic Invest 133.","DOI":"10.1172\/JCI163735"},{"key":"2385_CR32","volume":"39","author":"Y Hou","year":"2025","unstructured":"Hou Y, Yang Y, Zhao Z, Wang S, Chen X, Xie Y, Chen H, Xu J (2025) Capsazepine inhibits astrocyte activation and attenuates neuroinflammation by targeting syntaxin 7. FASEB J 39:e70657","journal-title":"FASEB J"},{"key":"2385_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031771","author":"IH Hsiao","year":"2024","unstructured":"Hsiao IH, Yen C-M, Hsu H-C, Liao H-Y, Lin Y-W (2024) Chemogenetics modulation of electroacupuncture analgesia in mice spared nerve injury-induced neuropathic pain through TRPV1 signaling pathway. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25031771","journal-title":"Int J Mol Sci"},{"key":"2385_CR34","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1080\/17581869.2025.2535271","volume":"15","author":"M Iadarola","year":"2025","unstructured":"Iadarola M, Sapio M, Nahama A, Mannes A (2025) Intraarticular resiniferatoxin, a potent TRPV1 agonist, for treatment of osteoarthritic pain. Pain Manag 15:659\u2013670","journal-title":"Pain Manag"},{"key":"2385_CR35","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136380","volume":"768","author":"LF Iannone","year":"2022","unstructured":"Iannone LF, De Logu F, Geppetti P, De Cesaris F (2022) The role of TRP ion channels in migraine and headache. Neurosci Lett 768:136380","journal-title":"Neurosci Lett"},{"key":"2385_CR36","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12974-022-02485-z","volume":"19","author":"J Joffre","year":"2022","unstructured":"Joffre J, Wong E, Lawton S, Lloyd E, Nguyen N, Xu F, Sempio C, Kobzik L, Zlatanova I, Schumacher M (2022) N-Oleoyl dopamine induces IL-10 via central nervous system TRPV1 and improves endotoxemia and sepsis outcomes. J Neuroinflammation 19:118","journal-title":"J Neuroinflammation"},{"key":"2385_CR37","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1124\/jpet.111.183053","volume":"340","author":"K Kaszas","year":"2012","unstructured":"Kaszas K, Keller JM, Coddou C, Mishra SK, Hoon MA, Stojilkovic S, Jacobson KA, Iadarola MJ (2012) Small molecule positive allosteric modulation of TRPV1 activation by vanilloids and acidic pH. J Pharmacol Exp Ther 340:152\u2013160","journal-title":"J Pharmacol Exp Ther"},{"key":"2385_CR38","volume":"75","author":"A-P Koivisto","year":"2024","unstructured":"Koivisto A-P, Voets T, Iadarola M, Szallasi A (2024a) Targeting TRP channels for pain relief: a review of current evidence from bench to bedside. Curr Opin Pharmacol 75:102447","journal-title":"Curr Opin Pharmacol"},{"key":"2385_CR39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12974-025-03421-7","volume":"22","author":"S Kong","year":"2025","unstructured":"Kong S, Jia X, Liang X, Chen Y, Liang J, Zhang Y, Wu N, Su S, Chen T, He X (2025) Febrile temperature-regulated TRPV1 in CD4+ T cells mediates neuroinflammation in complex febrile seizures. J Neuroinflammation 22:103","journal-title":"J Neuroinflammation"},{"key":"2385_CR40","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41594-021-00616-3","volume":"28","author":"D Kwon","year":"2021","unstructured":"Kwon D, Zhang F, Suo Y, Bouvette J, Borgnia M, Lee S-Y (2021) Heat-dependent opening of TRPV1 in the presence of capsaicin. Nat Struct Mol Biol 28:554\u2013563","journal-title":"Nat Struct Mol Biol"},{"key":"2385_CR41","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s12951-022-01551-1","volume":"20","author":"W-S Lee","year":"2022","unstructured":"Lee W-S, Kang J-H, Lee J-H, Kim YS, Kim JJ, Kim H-S, Kim H-W, Shin US, Yoon B-E (2022) Improved gliotransmission by increasing intracellular Ca2+ via TRPV1 on multi-walled carbon nanotube platforms. J Nanobiotechnol 20:367","journal-title":"J Nanobiotechnol"},{"key":"2385_CR42","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.7150\/ijbs.59918","volume":"17","author":"L Li","year":"2021","unstructured":"Li L, Chen C, Chiang C, Xiao T, Chen Y, Zhao Y, Zheng D (2021a) The impact of TRPV1 on cancer pathogenesis and therapy: a systematic review. Int J Biol Sci 17:2034","journal-title":"Int J Biol Sci"},{"key":"2385_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101022","author":"Y Li","year":"2021","unstructured":"Li Y, Chen X, Nie Y, Tian Y, Xiao X, Yang F (2021b) Endocannabinoid activation of the TRPV1 ion channel is distinct from activation by capsaicin. J Biol Chem. https:\/\/doi.org\/10.1016\/j.jbc.2021.101022","journal-title":"J Biol Chem"},{"key":"2385_CR44","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/15360288.2025.2500984","volume":"39","author":"Y Li","year":"2025","unstructured":"Li Y, Li C, Zhu H, Chu Y (2025) TRPV1 in dorsal root ganglion contributed to chronic pancreatitis pain. J Pain Palliat Care Pharmacother 39:384\u2013392","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"2385_CR45","volume":"31","author":"S Li","year":"2026","unstructured":"Li S, He Y, Kam H, Chen H, Bian J-S, Xu N, Gong G, Liao Q, Zhao C, Yang B (2026) Discovery of rhubarb anthraquinones physcion and rhein as functional inhibitors of TRPV1 against lipopolysaccharide-induced neuroinflammation. Molecules 31:2049","journal-title":"Molecules"},{"key":"2385_CR46","volume":"25","author":"H-Y Liao","year":"2024","unstructured":"Liao H-Y, Yen C-M, Hsiao I-H, Hsu H-C, Lin Y-W (2024) Eicosapentaenoic acid modulates transient receptor potential V1 expression in specific brain areas in a mouse fibromyalgia pain model. Int J Mol Sci 25:2901","journal-title":"Int J Mol Sci"},{"key":"2385_CR47","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10616-025-00806-7","volume":"77","author":"M Liu","year":"2025","unstructured":"Liu M, Wang Y (2025b) S1P receptor 1 antagonist ponesimod alleviates postherpetic neuralgia in rats by normalizing spinal TRPV1 expression and inhibiting MAPK-mediated glial activation. Cytotechnology 77:141","journal-title":"Cytotechnology"},{"key":"2385_CR48","volume":"131","author":"C Liu","year":"2025","unstructured":"Liu C, Miao R, Wang N, Zhang C, Qian H, Tian X (2025) Optimization of novel TRPV1 antagonists bearing 1-((2,2-difluorobenzo[d][1,3] dioxol-5-yl) methyl) piperazine for pain management: mechanistic insights into NLRP3 inflammasome modulation. Bioorg Med Chem 131:118415","journal-title":"Bioorg Med Chem"},{"key":"2385_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1631\/jzus.B2500209","volume":"27","author":"Y Liu","year":"2026","unstructured":"Liu Y, Duan F, Lin R, Shabuerjiang S, Yang F, Aierken A (2026) TRPV1: from structure to function\u2014a multidimensional target for therapeutic advances. J Zhejiang Univ-Sci B 27:1\u201322","journal-title":"J Zhejiang Univ-Sci B"},{"key":"2385_CR50","doi-asserted-by":"crossref","unstructured":"Liu, M. & Wang, Y. 2025a. S1P receptor 1 antagonist ponesimod alleviates postherpetic neuralgia in rats by normalizing spinal TRPV1 expression and inhibiting MAPK-mediated glial activation. Cytotechnology, 77.","DOI":"10.1007\/s10616-025-00806-7"},{"key":"2385_CR51","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12974-022-02484-0","volume":"19","author":"J Lu","year":"2022","unstructured":"Lu J, Wang C, Cheng X, Wang R, Yan X, He P, Chen H, Yu Z (2022) A breakdown in microglial metabolic reprogramming causes internalization dysfunction of \u03b1-synuclein in a mouse model of Parkinson\u2019s disease. J Neuroinflammation 19:113","journal-title":"J Neuroinflammation"},{"key":"2385_CR52","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40035-024-00445-6","volume":"13","author":"J Lu","year":"2024","unstructured":"Lu J, Wu K, Sha X, Lin J, Chen H, Yu Z (2024) TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer\u2019s disease. Transl Neurodegener 13:52","journal-title":"Transl Neurodegener"},{"key":"2385_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09965-6","volume":"10","author":"L Luo","year":"2019","unstructured":"Luo L, Wang Y, Li B, Xu L, Kamau PM, Zheng J, Yang F, Yang S, Lai R (2019) Molecular basis for heat desensitization of TRPV1 ion channels. Nat Commun 10:2134","journal-title":"Nat Commun"},{"key":"2385_CR54","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/23328940.2021.1983354","volume":"10","author":"D Luu","year":"2021","unstructured":"Luu D, Owens A, Mebrat M, van Horn W (2021) A molecular perspective on identifying TRPV1 thermosensitive regions and disentangling polymodal activation. Temperature 10:67\u2013101","journal-title":"Temperature"},{"key":"2385_CR55","doi-asserted-by":"crossref","unstructured":"Lv, Z., Xu, X., Sun, Z.-Y., Yang, Y., Guo, H., Li, J., Sun, K.-Y., Wu, R., Xu, J., Jiang, Q., Ikegawa, S. & Shi, D. 2021. TRPV1 alleviates osteoarthritis by inhibiting M1 macrophage polarization via Ca2+\/CaMKII\/Nrf2 signaling pathway. Cell Death & Disease, 12.","DOI":"10.1038\/s41419-021-03792-8"},{"key":"2385_CR56","volume":"15","author":"W Ma","year":"2022","unstructured":"Ma W, Sapio MR, Manalo AP, Maric D, Dougherty MK, Goto T, Mannes AJ, Iadarola MJ (2022) Anatomical analysis of transient potential vanilloid receptor 1 (Trpv1+) and mu-opioid receptor (Oprm1+) co-expression in rat dorsal root ganglion neurons. Front Mol Neurosci 15:926596","journal-title":"Front Mol Neurosci"},{"key":"2385_CR57","doi-asserted-by":"crossref","unstructured":"Manchanda, M., Leishman, E., Sangani, K., Alamri, A. & Bradshaw, H. 2021. Activation of TRPV1 by Capsaicin or Heat Drives Changes in 2-Acyl Glycerols and N-Acyl Ethanolamines in a Time, Dose, and Temperature Dependent Manner. Front Cell Deve Biol 9.","DOI":"10.3389\/fcell.2021.611952"},{"key":"2385_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15292","volume":"8","author":"MC Marrone","year":"2017","unstructured":"Marrone MC, Morabito A, Giustizieri M, Chiurchi\u00f9 V, Leuti A, Mattioli M, Marinelli S, Riganti L, Lombardi M, Murana E (2017) TRPV1 channels are critical brain inflammation detectors and neuropathic pain biomarkers in mice. Nat Commun 8:15292","journal-title":"Nat Commun"},{"key":"2385_CR59","volume":"119","author":"TKE Maximiano","year":"2024","unstructured":"Maximiano TKE, Carneiro JA, Fattori V, Verri WA (2024) TRPV1: receptor structure, activation, modulation and role in neuro-immune interactions and pain. Cell Calcium 119:102870","journal-title":"Cell Calcium"},{"key":"2385_CR60","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1080\/14728222.2024.2416961","volume":"28","author":"A Mobasheri","year":"2024","unstructured":"Mobasheri A, Rannou F, Ivanavicius S, Conaghan P (2024) Targeting the TRPV1 pain pathway in osteoarthritis of the knee. Expert Opin Ther Targets 28:843\u2013856","journal-title":"Expert Opin Ther Targets"},{"key":"2385_CR61","doi-asserted-by":"publisher","DOI":"10.5530\/pj.2024.16.196","author":"DR Mumpuni","year":"2024","unstructured":"Mumpuni DR, Putri HS, Airlangga PS, Waloejo CS (2024) Transient receptor potential vanilloid 1 in acute pain: a literature review. Pharmacogn J. https:\/\/doi.org\/10.5530\/pj.2024.16.196","journal-title":"Pharmacogn J"},{"key":"2385_CR62","volume":"2","author":"TJ Mungoven","year":"2021","unstructured":"Mungoven TJ, Henderson LA, Meylakh N (2021) Chronic migraine pathophysiology and treatment: a review of current perspectives. Front Pain Res (Lausanne) 2:705276","journal-title":"Front Pain Res (Lausanne)"},{"key":"2385_CR63","doi-asserted-by":"crossref","unstructured":"Nagasato, Y., Sanematsu, K., Kawabata, Y., Takai, S., Nakamura, S., Matsui, T. & Shigemura, N. 2025. In silico analysis of sodium ion permeation mechanisms in transient receptor potential vanilloid 1. Sci Rep 15.","DOI":"10.1038\/s41598-025-29092-1"},{"key":"2385_CR64","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2174\/1389201022666210719155931","volume":"23","author":"GG Naik","year":"2022","unstructured":"Naik GG, Uniyal A, Chouhan D, Tiwari V, Sahu AN (2022) Natural products and some semi-synthetic analogues as potential TRPV1 ligands for attenuating neuropathic pain. Curr Pharm Biotechnol 23:766\u2013786","journal-title":"Curr Pharm Biotechnol"},{"key":"2385_CR65","doi-asserted-by":"crossref","unstructured":"Nayeon, Zuo, D., Kim, M., Kim, M., Ha, H., Blumberg, P., Ann, J., Hwang, S. W. & Lee, J. 2024. Discovery of Dual TRPA1 and TRPV1 Antagonists as Novel Therapeutic Agents for Pain. Pharmaceuticals 17.","DOI":"10.3390\/ph17091209"},{"key":"2385_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38162-9","volume":"14","author":"A Neuberger","year":"2023","unstructured":"Neuberger A, Oda M, Nikolaev YA, Nadezhdin KD, Gracheva EO, Bagriantsev SN, Sobolevsky AI (2023b) Human TRPV1 structure and inhibition by the analgesic SB-366791. Nat Commun 14:2451","journal-title":"Nat Commun"},{"key":"2385_CR67","doi-asserted-by":"crossref","unstructured":"Neuberger, A., Oda, M., Nikolaev, Y., Nadezhdin, K., Gracheva, E., Bagriantsev, S. & Sobolevsky, A. 2023a. Human TRPV1 structure and inhibition by the analgesic SB-366791. Nature Commun 14.","DOI":"10.1038\/s41467-023-38162-9"},{"key":"2385_CR68","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1152\/physrev.00021.2006","volume":"87","author":"B Nilius","year":"2007","unstructured":"Nilius B, Owsianik G, Voets T, Peters JA (2007) Transient receptor potential cation channels in disease. Physiol Rev 87:165\u2013217","journal-title":"Physiol Rev"},{"key":"2385_CR69","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/med.21945","volume":"43","author":"M Oz","year":"2023","unstructured":"Oz M, Lorke DE, Howarth FC (2023) Transient receptor potential vanilloid 1 (TRPV1)-independent actions of capsaicin on cellular excitability and ion transport. Med Res Rev 43:1038\u20131067","journal-title":"Med Res Rev"},{"issue":"2023","key":"2385_CR70","doi-asserted-by":"crossref","first-page":"1232013","DOI":"10.3389\/fimmu.2023.1232013","volume":"14","author":"Y Qu","year":"2023","unstructured":"Qu Y, Fu Y, Liu Y, Liu C, Xu B, Zhang Q, Jiang P (2023) The role of TRPV1 in RA pathogenesis: worthy of attention. Front Immunol 14(2023):1232013","journal-title":"Front Immunol"},{"key":"2385_CR71","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122954","volume":"355","author":"MM Rahman","year":"2024","unstructured":"Rahman MM, Jo Y-Y, Kim YH, Park C-K (2024a) Current insights and therapeutic strategies for targeting TRPV1 in neuropathic pain management. Life Sci 355:122954","journal-title":"Life Sci"},{"key":"2385_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122954","author":"MM Rahman","year":"2024","unstructured":"Rahman MM, Jo Y, Kim YH, Park C-K (2024b) Current insights and therapeutic strategies for targeting TRPV1 in neuropathic pain management. Life Sci. https:\/\/doi.org\/10.1016\/j.lfs.2024.122954","journal-title":"Life Sci"},{"key":"2385_CR73","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/ejp.2017","volume":"26","author":"G Robilotto","year":"2022","unstructured":"Robilotto G, Mohapatra D, Shepherd A, Mickle A (2022) Role of Src kinase in regulating protein kinase C mediated phosphorylation of TRPV1. Eur J Pain 26:1967\u20131978","journal-title":"Eur J Pain"},{"key":"2385_CR74","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/bph.16003","volume":"180","author":"MC Ruiz\u2010Cantero","year":"2023","unstructured":"Ruiz\u2010Cantero MC, Cort\u00e9s\u2010Montero E, Jain A, Montilla\u2010Garc\u00eda \u00c1, Bravo\u2010Caparr\u00f3s I, Shim J, S\u00e1nchez\u2010Bl\u00e1zquez P, Woolf CJ, Baeyens JM, Cobos EJ (2023) The sigma\u20101 receptor curtails endogenous opioid analgesia during sensitization of TRPV1 nociceptors. Br J Pharmacol 180:1148\u20131167","journal-title":"Br J Pharmacol"},{"key":"2385_CR75","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41419-024-07328-8","volume":"16","author":"X Sha","year":"2025","unstructured":"Sha X, Lin J, Wu K, Lu J, Yu Z (2025) The TRPV1-PKM2-SREBP1 axis maintains microglial lipid homeostasis in Alzheimer\u2019s disease. Cell Death Dis 16:14","journal-title":"Cell Death Dis"},{"key":"2385_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2025.138413","author":"C Shao","year":"2025","unstructured":"Shao C, Wei J, Jia H-Y, Zhou Y-H, Zhao M, Yang K, Zhang M-M (2025) Differential expression of TRPV1 and TRPM8 in the mouse trigeminal ganglion and spinal dorsal root ganglion. Neurosci Lett. https:\/\/doi.org\/10.1016\/j.neulet.2025.138413","journal-title":"Neurosci Lett"},{"key":"2385_CR77","first-page":"2771","volume":"529","author":"SI Shiers","year":"2021","unstructured":"Shiers SI, Sankaranarayanan I, Jeevakumar V, Cervantes A, Reese JC, Price TJ (2021) Convergence of peptidergic and non-peptidergic protein markers in the human dorsal root ganglion and spinal dorsal horn. J Comp Neurol 529:2771\u20132788","journal-title":"J Comp Neurol"},{"key":"2385_CR78","doi-asserted-by":"crossref","unstructured":"silverman, H., Chen, A., Kravatz, N., Chavan, S. & Chang, E. 2020. Involvement of neural transient receptor potential channels in peripheral inflammation. Front Immunol 11.","DOI":"10.3389\/fimmu.2020.590261"},{"key":"2385_CR79","doi-asserted-by":"crossref","first-page":"700","DOI":"10.3390\/ijms24010700","volume":"24","author":"E Spekker","year":"2022","unstructured":"Spekker E, K\u00f6rt\u00e9si T, V\u00e9csei L (2022) TRP channels: recent development in translational research and potential therapeutic targets in migraine. Int J Mol Sci 24:700","journal-title":"Int J Mol Sci"},{"key":"2385_CR80","doi-asserted-by":"crossref","first-page":"5806321","DOI":"10.1155\/2019\/5806321","volume":"2019","author":"MV Storozhuk","year":"2019","unstructured":"Storozhuk MV, Moroz OF, Zholos AV (2019) Multifunctional TRPV1 ion channels in physiology and pathology with focus on the brain, vasculature, and some visceral systems. Biomed Res Int 2019:5806321","journal-title":"Biomed Res Int"},{"issue":"10","key":"2385_CR81","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.scib.2022.02.016","volume":"67","author":"M Sun","year":"2022","unstructured":"Sun M, Zhang X, Peng Y, Liu D-S, Yang Y, Cui W-W, Yang X-N, Lei Y-T, Li X, Wang W-H, Cao P, Wang H, Zhu M, Li C-Z, Rui W, Fan Y-Z, Yu Y (2022) Vanilloid agonist-mediated activation of TRPV1 channels requires coordinated movement of the S1\u2013S4 bundle rather than a quiescent state. Sci Bull 67(10):1062\u20131076","journal-title":"Sci Bull"},{"key":"2385_CR82","volume":"24","author":"A Szallasi","year":"2023","unstructured":"Szallasi A (2023) Resiniferatoxin: nature\u2019s precision medicine to silence TRPV1-positive afferents. Int J Mol Sci 24:15042","journal-title":"Int J Mol Sci"},{"key":"2385_CR83","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.npep.2004.07.005","volume":"38","author":"J Szolcs\u00e1nyi","year":"2004","unstructured":"Szolcs\u00e1nyi J (2004) Forty years in capsaicin research for sensory pharmacology and physiology. Neuropeptides 38:377\u2013384","journal-title":"Neuropeptides"},{"key":"2385_CR84","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.672157","volume":"12","author":"K Takahashi","year":"2021","unstructured":"Takahashi K, Araki K, Miyamoto H, Shirakawa R, Yoshida T, Wakamori M (2021) Capsaicin and proton differently modulate activation kinetics of mouse transient receptor potential Vanilloid-1 channel induced by depolarization. Front Pharmacol 12:672157","journal-title":"Front Pharmacol"},{"key":"2385_CR85","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj8186","volume":"14","author":"D Tavares-Ferreira","year":"2022","unstructured":"Tavares-Ferreira D, Shiers S, Ray PR, Wangzhou A, Jeevakumar V, Sankaranarayanan I, Cervantes AM, Reese JC, Chamessian A, Copits BA (2022) Spatial transcriptomics of dorsal root ganglia identifies molecular signatures of human nociceptors. Sci Transl Med 14:eabj8186","journal-title":"Sci Transl Med"},{"key":"2385_CR86","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s40263-026-01272-1","volume":"40","author":"EH Tsai","year":"2026","unstructured":"Tsai EH, Gan TJ (2026) TRPV1 receptor modulators: emerging therapies for neuropathic, osteoarthritic, and perioperative pain: EH Tsai, TJ Gan. CNS Drugs 40:523\u2013534","journal-title":"CNS Drugs"},{"key":"2385_CR87","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3390\/molecules29010181","volume":"29","author":"W Wang","year":"2023","unstructured":"Wang W, Sun T (2023a) Impact of TRPV1 on pathogenesis and therapy of neurodegenerative diseases. Molecules 29:181","journal-title":"Molecules"},{"key":"2385_CR88","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29010181","author":"W Wang","year":"2023","unstructured":"Wang W, Sun T (2023b) Impact of TRPV1 on pathogenesis and therapy of neurodegenerative diseases. Molecules. https:\/\/doi.org\/10.3390\/molecules29010181","journal-title":"Molecules"},{"key":"2385_CR89","volume":"12","author":"C Wang","year":"2022","unstructured":"Wang C, Huang W, Lu J, Chen H, Yu Z (2022) TRPV1-mediated microglial autophagy attenuates Alzheimer\u2019s disease-associated pathology and cognitive decline. Front Pharmacol 12:763866","journal-title":"Front Pharmacol"},{"key":"2385_CR90","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s12276-023-00935-z","volume":"55","author":"C Wang","year":"2023","unstructured":"Wang C, Lu J, Sha X, Qiu Y, Chen H, Yu Z (2023) TRPV1 regulates ApoE4-disrupted intracellular lipid homeostasis and decreases synaptic phagocytosis by microglia. Exp Mol Med 55:347\u2013363","journal-title":"Exp Mol Med"},{"key":"2385_CR91","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3390\/ijms26020662","volume":"26","author":"P Xu","year":"2025","unstructured":"Xu P, Shao R, Zhu P, Fei J, He Y (2025) The role of TRPV1\/CGRP pathway activated by Prevotella melaninogenica in pathogenesis of oral lichen planus. Int J Mol Sci 26:662","journal-title":"Int J Mol Sci"},{"key":"2385_CR92","doi-asserted-by":"crossref","unstructured":"Yue, W., Yuan, L., Braz, J., Basbaum, A. & Julius, D. 2022. TRPV1 drugs alter core body temperature via central projections of primary afferent sensory neurons. eLife 11.","DOI":"10.7554\/eLife.80139"},{"key":"2385_CR93","doi-asserted-by":"crossref","unstructured":"Zhai, K., L\u00ed\u0161kov\u00e1, A., Kubatka, P. & B\u00fcsselberg, D. 2020. Calcium entry through TRPV1: a potential target for the regulation of proliferation and apoptosis in cancerous and healthy cells. Int J Mol Sc 21.","DOI":"10.3390\/ijms21114177"},{"key":"2385_CR94","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/s41419-021-04450-9","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Hou B, Liang P, Lu X, Wu Y, Zhang X, Fan Y, Liu Y, Chen T, Liu W (2021) TRPV1 channel mediates NLRP3 inflammasome-dependent neuroinflammation in microglia. Cell Death Dis 12:1159","journal-title":"Cell Death Dis"},{"key":"2385_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/ani12243593","author":"L Zhang","year":"2022","unstructured":"Zhang L, Li N, Dayananda B, Wang L, Chen H, Cao Y (2022) Genome-wide identification and phylogenetic analysis of TRP gene family members in saurian. Animals (Basel). https:\/\/doi.org\/10.3390\/ani12243593","journal-title":"Animals (Basel)"},{"key":"2385_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34817-1","volume":"14","author":"H Zhang","year":"2023","unstructured":"Zhang H, Lin J-J, Xie Y-K, Song X-Z, Sun J-Y, Zhang B-L, Qi Y-K, Xu Z-Z, Yang F (2023a) Structure-guided peptide engineering of a positive allosteric modulator targeting the outer pore of TRPV1 for long-lasting analgesia. Nat Commun 14:4","journal-title":"Nat Commun"},{"key":"2385_CR97","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.18632\/aging.205379","volume":"16","author":"K Zhang","year":"2024","unstructured":"Zhang K, Qin Z, Chen J, Guo G, Jiang X, Wang F, Zhuang J, Zhang Z (2024) TRPV1 modulated NLRP3 inflammasome activation via calcium in experimental subarachnoid hemorrhage. Aging (Albany NY) 16:1096","journal-title":"Aging (Albany NY)"},{"key":"2385_CR98","volume":"15","author":"M Zhang","year":"2025","unstructured":"Zhang M, Wang Z, Liu S, Li Y, Gong Y, Liu M (2025) New options for targeting TRPV1 receptors for cancer treatment: odorous Chinese herbal medicine. Front Oncol 15:1488289","journal-title":"Front Oncol"},{"key":"2385_CR99","doi-asserted-by":"crossref","unstructured":"Zhang, H., Lin, J., Xie, Y.-K., Song, X.-Z., Sun, J., Zhang, B., Qi, Y.-K., Xu, Z.-Z. & Yang, F. 2023b. Structure-guided peptide engineering of a positive allosteric modulator targeting the outer pore of TRPV1 for long-lasting analgesia. Nature Commun 14.","DOI":"10.1038\/s41467-022-34817-1"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02385-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02385-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02385-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:55:51Z","timestamp":1792194951000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02385-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":99,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2385"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02385-1","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"11 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no financial or intellectual conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that no AI-generated content was used in the preparation of this manuscript.","order":2,"name":"Ethics","label":"AI Declaration","group":{"name":"EthicsHeading","label":"Declarations"}}]}}